Latest filing published 29 Jun 2016 for DiaMedica Inc., €7,293.
Michael Giuffre is a declared insider of DiaMedica Inc., with filings sourced from SEDI. In total, 4 filings cover trades dated 24 June 2016.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 29 June 2016: an option exercise of €7,293, in DiaMedica Inc. Filings reach the SEDI feed a median of 5 days after the trade. The shorter that gap, the sooner other investors can see what insiders have done. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations